Home
Univercells

Univercells Market Share Analysis for June 2026

We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.

Health > Biotechnology and Pharmaceuticals

Domainunivercells.com

Year Founded2013

Employees201 - 500

Annual Revenue$10M - $15M

Univercells

Univercells (including company regionals)

univercells.com

See more website traffic and engagement information

Univercells Revenue up to June 2026 is 10M - 15M

revenue generated by Univercells top domains

Univercells top domains revenue over 3 years

Revenue for Univercells top domains

univercells.com10M - 15M

See more with Sales Intelligence

Total visits to Univercells's top domains

Understand Univercells market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

univercells.com517

See more with Sales Intelligence

Avg. visit duration in Univercells's top domains

Analyze Univercells engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Univercells's top domains

See how Univercells keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

univercells.com1.01

See more with Sales Intelligence

Univercells top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Univercells

These are the website technologies, by industry, used by Univercells top domains

Advertising (5)

DoubleClick

Widget (4)

Twemoji

Content Management System (3)

WordPress

Business Solutions (2)

Wild Apricot

More Technologies

11

See all

News & Signals from Univercells

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOxford Cancer Biomarkers Ltd partners with Univercells.Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with belgian biotech innovator, Univercells.

NewsSerum Institute of India Limited partners with Univercells.Serum Institute of India (SII) has joined forces with Univercells, a Belgian biotech innovator, to increase accessibility to personalised cancer care.

NewsUnivercells is developing vivo and in vitro messenger RNA vaccine.Univercells Group will test in vivo and in vitro messenger RNA (mRNA) vaccine with Altamira Therapeutics' SemaPhore nanoparticle platform.